Bluejay Diagnostics (BJDX) Payables (2022 - 2023)
Bluejay Diagnostics (BJDX) has disclosed Payables for 2 consecutive years, with $1.9 million as the latest value for Q3 2023.
- Quarterly Payables rose 323.32% to $1.9 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Sep 2023, up 323.32% year-over-year, with the annual reading at $635818.0 for FY2022, N/A changed from the prior year.
- Payables hit $1.9 million in Q3 2023 for Bluejay Diagnostics, up from $271488.0 in the prior quarter.
- In the past five years, Payables ranged from a high of $1.9 million in Q3 2023 to a low of $196108.0 in Q2 2022.